---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-245203"
form_type: "8-K"
ticker: "TEVA"
cik: "0000818686"
company_name: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
filed_at: "2026-05-28T20:05:43+00:00"
generated_at: "2026-05-28T21:16:13.108895+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Teva shareholders re-elect Sol J. Barer to board, approve advisory pay vote

## Summary
- Dr. Sol J. Barer elected to board with 627.8M for, 245.9M against, 0.5M abstain (broker non-votes 50.7M).
- Non-binding advisory compensation proposal passed with 796.0M for, 77.1M against, 1.2M abstain.
- Kesselman & Kesselman (PwC) ratified as independent auditor for 2027 with 880.5M for, 36.1M against.

## SEC filing metadata
- accession: 0001193125-26-245203
- form_type: 8-K
- ticker: TEVA
- cik: 0000818686
- company_name: TEVA PHARMACEUTICAL INDUSTRIES LTD
- filed_at: 2026-05-28T20:05:43+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818686/000119312526245203/0001193125-26-245203-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818686/000119312526245203/d342755d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-245203
- JSON: https://secwatch.observer/filing/0001193125-26-245203.json
- Plain text: https://secwatch.observer/filing/0001193125-26-245203.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.